Oncofocus
  • Services
    • Primary Market Research
    • Competitive Intelligence
  • About
  • Resources
    • Blog
    • Reports >
      • 2019 BCMA CAR-T Report
      • 2019 Melanoma Report
      • 2019 CAR-T Pipeline Landscape Report 2019
      • ICIs in SCLC: Report >
        • ICIs in SCLC: Pipeline Landscape
      • CCa Awareness Study
  • CSR
  • Careers
  • Contact

All work and no blog will make us dull blokes!

That’s why we keenly follow Oncology domain and blog
​on topics of varied interest. ​The idea is to share, learn and evolve!

Cancer Statistics #02

25/9/2019

0 Comments

 
Picture

​15th of September is observed as the World Lymphoma Awareness Day (WLAD) to raise awareness, while September is the Lymphoma Awareness Month.  In connection to the WLAD, we present an infographic depicting the burden of the two main sub-types of Lymphoma - Hodgkin's and Non-Hodgkin's disease - in the APAC region.

Read More
0 Comments

Interview #06

12/9/2019

0 Comments

 

Lymphoma – A Basic Understanding
​​(Focus: India)

Picture
Cancer awareness is a continuous exercise that requires a multi-dimensional approach and proactive involvement of every stakeholder. Oncofocus, being a management consulting and research firm, will be publishing every month a short interview with leading Oncologists across the APAC region on a particular Cancer type. The main objective of these interviews is to learn the "What, Why, How" of the present state of cancer management directly from the treaters. ​


​​September being the 
Lymphoma Awareness Month, we decided to focus on lymphoma, in the second post of our cancer interview series. Our analyst Ms. Shilna Kunnath connected with Dr Anil Kumar MR, consultant radiation oncologist and CEO of Bangalore Cancer Centre and discussed about lymphoma in general.



The advent of rituximab itself changed the prognosis of Non-Hodgkin’s lymphoma. Being a very specific, chimeric monoclonal antibody, it targets only the cells expressing CD20 marker.

Read More
0 Comments

Interview #05

19/8/2019

0 Comments

 

​Real-World Data and Real-World Evidence: Current status in the APAC region
​​(Focus: Malaysia)

Our senior analyst Shimi Manayath Panakkal discussed about the usage of Real-World Data and Real-World Evidence in Malaysia with Dr Sattian Kollanthavelu from Hospital Selayang, Malaysia. This is our fourth post in our interview series on Real-World Data.
           . . . will help in understanding the overall trends in terms of disease burden and help in allocating funds accordingly

Read More
0 Comments

Interview #04

9/8/2019

0 Comments

 

Lung Cancer – A Basic Understanding
(Focus: Malaysia)

Picture
​Cancer awareness is a continuous exercise that requires a multi-dimensional approach and proactive involvement of every stakeholder. Oncofocus, being a management consulting and research firm, will be publishing every month a short interview with leading Oncologists across the APAC region on a particular Cancer type. The main objective of these interviews is to learn the "What, Why, How" of the present state of cancer management directly from the treaters. 
​

​​​As August 01 is marked as the World Lung Cancer Day, our analyst Ms. Rihana Kuniyilakath connected with Dr Vaishnavi Jeyasingam, clinical o​ncologist from Hospital Kuala Lumpur, a government tertiary referral hospital, that serves as a flagship hospital of the Malaysian public healthcare system

... newer drugs like osimertinib, alectinib, crizotinib etc. are also available ... Some of these molecular therapies have exorbitant prices and are beyond the reach of average citizens.

Read More
0 Comments

Cancer Statistics #01

9/8/2019

0 Comments

 
Picture

​The first day on August is observed as the 
World Lung Cancer Day to raise awareness about the impact of lung cancer.  In connection to the World Lung Cancer Day, we present an infographic depicting the burden of Lung cancer in the APAC region.

Read More
0 Comments

Case Study #04

9/8/2019

0 Comments

 

Promotional Messaging Support for a Scandinavian Medical Device Company
​​(Focus: APAC)

Picture

​A Scandinavian medical device company entering the APAC market, needed support in choosing the content for promotional messaging, for its newly launched Point of Care (PoC) device. Read more to know how we helped our client with this problem.


Read More
0 Comments

Interview #03

8/8/2019

0 Comments

 

Real-World Data and Real-World Evidence: Current status in the APAC region
​​(Focus: India)

In the third interview of our the Real-World Data series, our analyst Shilna Kunnath connected with Dr. Randeep Singh, Director Medical Oncologist, Narayana Hospitals and Oncomed Clinic, Delhi/NCR to discuss about the current status of Real-world Data usage in India.
... real-world data is helpful in clinical evaluation of rare diseases where conducting regular controlled trials is not feasible.

Read More
0 Comments

Case Study #03

4/7/2019

1 Comment

 

Conference Impact Assessment of Global Medical Device Company
​​(Focus: APAC)

Picture

​
​Background: Our US-based client, with a portfolio of cardiology/oncology interventional medical devices, planned to understand brand awareness among customers by hosting a conference.


Read More
1 Comment

Interview #02

4/7/2019

1 Comment

 

Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Singapore)

In the second post of the interview series, our team members, Raja Mukesh Dokala, Senior Manager and Khusnuma Begum, Senior Analyst discussed the current status of RWD in Singapore with Prof Teo Eng Kiong, HoD, Department of Gastroenterology and Chairman, Medical Board, Changi General Hospital, Singapore.
Real world data is essential because it reflects what really happens! It also helps us track how many patients cannot afford it (an expensive therapy) and what percent actually gets successfully treated.

Read More
1 Comment

Interview #01

5/6/2019

0 Comments

 

Real-World Data and Real-World Evidence: Current status in the APAC region
(Focus: Australia)

The use of real-world data (RWD) to supplement randomized clinical trials has been a growing trend recently. Several companies started using RWD to make informed pricing and reimbursement decisions and are also exploring other ways to use RWD in developing their clinical pipeline. At the same time, several countries are deliberating on how to employ real-world evidence (RWE) in their drug approval process.
 ... Australia or anywhere else the biggest problem now is noise in the data.

Read More
0 Comments
<<Previous
Forward>>

    Categories

    All
    Cancer Awareness
    Cancer Statistics
    Case Studies
    Conference Reports
    HCPs Preferences
    Interviews
    Things To Know Series

Bangalore Office
Oncofocus Solutions Pvt Ltd, 

#4, II Floor, 5th Main, 9th Cross, Jaya Mahal Ext,
Bengaluru
, India 56 00 46

Tel. +91 89044 00482

E-mail: support@oncofocus.com
RFQ: rfq@oncofocus.com
​

Singapore Office (Sales)
Oncofocus Solutions Pte Ltd, 

51 Goldhill Plaza, 
#07-10/11
​Singapore 30 89 00
​



E-mail: support@oncofocus.com.sg
​RFQ: rfq@oncofocus.com
​

    Subscribe to our Newsletter

Subscribe to Newsletter
Tweets by oncofocus
  • Services
    • Primary Market Research
    • Competitive Intelligence
  • About
  • Resources
    • Blog
    • Reports >
      • 2019 BCMA CAR-T Report
      • 2019 Melanoma Report
      • 2019 CAR-T Pipeline Landscape Report 2019
      • ICIs in SCLC: Report >
        • ICIs in SCLC: Pipeline Landscape
      • CCa Awareness Study
  • CSR
  • Careers
  • Contact